Get the latest tech news
FDA approves landmark fibromyalgia drug that works like no other | People living with fibromyalgia will soon have access to a novel therapy designed to tackle the condition’s most elusive symptom: Poor-quality sleep.
Following decades of limited treatment options, people living with fibromyalgia will soon have access to a novel therapy designed to tackle the condition’s most elusive symptom: Poor-quality sleep. The US Food and Drug Administration (FDA) has just approved Tonmya, a non-opioid, under-the-tongue…
“The FDA approval of Tonmya as a first-line treatment for fibromyalgia represents a landmark advancement for the millions of people in the US suffering from the debilitating pain this condition causes,” said Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals. “The FDA approval of Tonmya as a first-line treatment for fibromyalgia represents a landmark advancement for the millions of people in the U.S. suffering from the debilitating pain this condition causes,” said Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals. “For many years, rheumatologists like myself and other healthcare professionals have had to manage fibromyalgia with limited options that do not adequately meet treatment needs for the majority of patients,” said Philip Mease, M.D., Director of Rheumatology Research at the Providence Swedish Medical Center and Clinical Professor at the University of Washington School of Medicine.
Or read this on r/tech
